×

Compositions for regenerating defective or absent myocardium

  • US 8,753,886 B1
  • Filed: 05/01/2013
  • Issued: 06/17/2014
  • Est. Priority Date: 07/15/2005
  • Status: Active Grant
First Claim
Patent Images

1. An injectable graft composition for myocardial tissue regeneration, comprising acellular heart extracellular matrix (ECM), said ECM comprising endogenous proteoglycans, transforming growth factor beta (TGF-β

  • ) and fibroblast growth factor-2 (FGF-2), said ECM further comprising an exogenously added vascular endothelial growth factor (VEGF), said VEGF being linked to said ECM, wherein said VEGF interacts with said proteoglycans to control matrix formation and remodeling, wherein, when said composition is administered to damaged cardiovascular tissue, said composition induces stem cell proliferation and differentiation of stem cells into cardiomyocytes.

View all claims
  • 4 Assignments
Timeline View
Assignment View
    ×
    ×